USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation

Human Molecular Genetics

Volumn 20, Issue 11, 2011, Pages 2171-2181

  Guervilly, Jean Hugues ^a,c   Renaud, Emilie ^a   Takata, Minoru ^b   Rosselli, Filippo ^a  

^a Gustave Roussy Comprehensive Cancer Institute   (France)

^b KYOTO UNIVERSITY   (Japan)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; CYCLINE; DAMAGE SPECIFIC DNA BINDING PROTEIN 1; DNA BINDING PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; PEPTIDASE; UNCLASSIFIED DRUG; USP1 DEUBIQUITINASE;

ARTICLE; CELL CYCLE; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME STABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

CELL CYCLE; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; DOWN-REGULATION; ENDOPEPTIDASES; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; HEK293 CELLS; HELA CELLS; HUMANS; PHENOTYPE; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 79956027089     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr103     Document Type: Article

References (61)

1. Harper, J.W. and Elledge, S.J. (2007) The DNA damage response: ten years after. Mol. Cell, 28, 739-745.
2. Ciccia, A. and Elledge, S.J. (2010) The DNA damage response: making it safe to play with knives. Mol. Cell, 40, 179-204.
3. Cimprich, K.A. and Cortez, D. (2008) ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol., 9, 616-627.
4. Collis, S.J., Barber, L.J., Clark, A.J., Martin, J.S., Ward, J.D. and Boulton, S.J. (2007) HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. Nat. Cell Biol., 9, 391-401.
5. Guervilly, J.H., Mace-Aime, G. and Rosselli, F. (2008) Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia. Hum. Mol. Genet., 17, 679-689.
6. Wang, X., Kennedy, R.D., Ray, K., Stuckert, P., Ellenberger, T. and D'Andrea, A.D. (2007) Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol. Cell Biol., 27, 3098-3108.
7. Yang, X.H., Shiotani, B., Classon, M. and Zou, L. (2008) Chk1 and Claspin potentiate PCNA ubiquitination. Genes Dev., 22, 1147-1152.
8. Sorensen, C.S., Hansen, L.T., Dziegielewski, J., Syljuasen, R.G., Lundin, C., Bartek, J. and Helleday, T. (2005) The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat. Cell Biol., 7, 195-201.
9. den Elzen, N.R. and O'Connell, M.J. (2004) Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk EMBO J., 23, 908-918.
10. Leung-Pineda, V., Huh, J. and Piwnica-Worms, H. (2009) DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res., 69, 2630-2637.
11. Zhang, Y.W., Brognard, J., Coughlin, C., You, Z., Dolled-Filhart, M., Aslanian, A., Manning, G., Abraham, R.T. and Hunter, T. (2009) The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress. Mol. Cell, 35, 442-453.
12. Faustrup, H., Bekker-Jensen, S., Bartek, J., Lukas, J. and Mailand, N. (2009) USP7 counteracts SCFbetaTrCP- but not APCCdh1-mediated proteolysis of Claspin. J. Cell Biol., 184, 13-19.
13. Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Dewhirst, M.W., Bigner, D.D. and Rich, J.N. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-760.
14. Cavelier, C., Didier, C., Prade, N., Mansat-De Mas, V., Manenti, S., Recher, C., Demur, C. and Ducommun, B. (2009) Constitutive activation of the DNA damage signaling pathway in acute myeloid leukemia with complex karyotype: potential importance for checkpoint targeting therapy. Cancer Res., 69, 8652-8661.
15. Didier, C., Cavelier, C., Quaranta, M., Galcera, M.O., Demur, C., Laurent, G., Manenti, S. and Ducommun, B. (2008) G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stress. Oncogene, 27, 3811-3820.
16. Hu, B., Zhou, X.Y., Wang, X., Zeng, Z.C., Iliakis, G. and Wang, Y. (2001) The radioresistance to killing of A1-5 cells derives from activation of the Chk1 pathway. J. Biol. Chem., 276, 17693-17698.
17. Lobitz, S. and Velleuer, E. (2006) Guido Fanconi (1892-1979): a jack of all trades. Nat. Rev. Cancer, 6, 893-898.
18. Kerzendorfer, C. and O'Driscoll, M. (2009) Human DNA damage response and repair deficiency syndromes: linking genomic instability and cell cycle checkpoint proficiency. DNA Repair (Amst.), 8, 1139-1152.
19. Wang, W. (2007) Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet., 8, 735-748.
20. Crossan, G.P., van der Weyden, L., Rosado, I.V., Langevin, F., Gaillard, P.H., McIntyre, R.E., Gallagher, F., Kettunen, M.I., Lewis, D.Y., Brindle, K. et al. (2011) Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia. Nat. Genet., 43, 147-152.
21. Kee, Y. and D'Andrea, A.D. (2010) Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev., 24, 1680-1694.
22. Kim, Y., Lach, F.P., Desetty, R., Hanenberg, H., Auerbach, A.D. and Smogorzewska, A. (2011) Mutations of the SLX4 gene in Fanconi anemia. Nat. Genet., 43, 142-146.
23. Levy-Lahad, E. (2010) Fanconi anemia and breast cancer susceptibility meet again. Nat. Genet., 42, 368-369.
24. O'Donnell, L. and Durocher, D. (2010) DNA repair has a new FAN1 club. Mol. Cell, 39, 167-169.
25. Stoepker, C., Hain, K., Schuster, B., Hilhorst-Hofstee, Y., Rooimans, M.A., Steltenpool, J., Oostra, A.B., Eirich, K., Korthof, E.T., Nieuwint, A.W. et al. (2011) SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat. Genet., 43, 138-141.
26. Adamo, A., Collis, S.J., Adelman, C.A., Silva, N., Horejsi, Z., Ward, J.D., Martinez-Perez, E., Boulton, S.J. and La Volpe, A. (2010) Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol. Cell, 39, 25-35.
27. Dray, E., Etchin, J., Wiese, C., Saro, D., Williams, G.J., Hammel, M., Yu, X., Galkin, V.E., Liu, D., Tsai, M.S. et al. (2010) Enhancement of RAD51 recombinase activity by the tumor suppressor PALB Nat. Struct. Mol. Biol., 17, 1255-1259.
28. Pace, P., Mosedale, G., Hodskinson, M.R., Rosado, I.V., Sivasubramaniam, M. and Patel, K.J. (2010) Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science, 329, 219-223.
29. Naim, V. and Rosselli, F. (2009) The FANC pathway and mitosis: a replication legacy. Cell Cycle, 8, 2907-2911.
30. Pichierri, P., Averbeck, D. and Rosselli, F. (2002) DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum. Mol. Genet., 11, 2531-2546.
31. Pichierri, P. and Rosselli, F. (2004) Fanconi anemia proteins and the s phase checkpoint. Cell Cycle, 3, 698-700.
32. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C., Hejna, J., Grompe, M. and D'Andrea, A.D. (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell, 7, 249-262.
33. Hirano, S., Yamamoto, K., Ishiai, M., Yamazoe, M., Seki, M., Matsushita, N., Ohzeki, M., Yamashita, Y.M., Arakawa, H., Buerstedde, J.M. et al. (2005) Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J., 24, 418-427.
34. Naim, V. and Rosselli, F. (2009) The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat. Cell Biol., 11, 761-768.
35. Nakanishi, K., Yang, Y.G., Pierce, A.J., Taniguchi, T., Digweed, M., D'Andrea, A.D., Wang, Z.Q. and Jasin, M. (2005) Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl Acad. Sci. USA, 102, 1110-1115.
36. Pichierri, P., Franchitto, A. and Rosselli, F. (2004) BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. EMBO J., 23, 3154-3163.
37. Andreassen, P.R., D'Andrea, A.D. and Taniguchi, T. (2004) ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev., 18, 1958-1963.
38. Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, D., Kesterton, I., Autore, F. et al. (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet., 42, 406-409.
39. Dutrillaux, B., Aurias, A., Dutrillaux, A.M., Buriot, D. and Prieur, M. (1982) The cell cycle of lymphocytes in Fanconi anemia. Hum. Genet., 62, 327-332.
40. Kaiser, T.N., Lojewski, A., Dougherty, C., Juergens, L., Sahar, E. and Latt, S.A. (1982) Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment. Cytometry, 2, 291-297.
41. Heinrich, M.C., Hoatlin, M.E., Zigler, A.J., Silvey, K.V., Bakke, A.C., Keeble, W.W., Zhi, Y., Reifsteck, C.A., Grompe, M., Brown, M.G. et al. (1998) DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood, 91, 275-287.
42. Nijman, S.M., Huang, T.T., Dirac, A.M., Brummelkamp, T.R., Kerkhoven, R.M., D'Andrea, A.D. and Bernards, R. (2005) The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell, 17, 331-339.
43. Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, E.R. 3rd, Hurov, K.E., Luo, J., Ballif, B.A., Gygi, S.P., Hofmann, K., D'Andrea, A.D. et al. (2007) Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell, 129, 289-301.
44. Huang, T.T., Nijman, S.M., Mirchandani, K.D., Galardy, P.J., Cohn, M.A., Haas, W., Gygi, S.P., Ploegh, H.L., Bernards, R. and D'Andrea, A.D. (2006) Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat. Cell Biol., 8, 339-347.
45. Matsushita, N., Kitao, H., Ishiai, M., Nagashima, N., Hirano, S., Okawa, K., Ohta, T., Yu, D.S., McHugh, P.J., Hickson, I.D. et al. (2005) A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell, 19, 841-847.
46. Kim, J.M., Parmar, K., Huang, M., Weinstock, D.M., Ruit, C.A., Kutok, J.L. and D'Andrea, A.D. (2009) Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev. Cell, 16, 314-320.
47. Oestergaard, V.H., Langevin, F., Kuiken, H.J., Pace, P., Niedzwiedz, W., Simpson, L.J., Ohzeki, M., Takata, M., Sale, J.E. and Patel, K.J. (2007) Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol. Cell, 28, 798-809.
48. Bogliolo, M., Lyakhovich, A., Callen, E., Castella, M., Cappelli, E., Ramirez, M.J., Creus, A., Marcos, R., Kalb, R., Neveling, K. et al. (2007) Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J., 26, 1340-1351.
49. Iliakis, G. (2010) New partners for Chk Cell Cycle, 9, 2059-2062.
50. Liu, S., Bekker-Jensen, S., Mailand, N., Lukas, C., Bartek, J. and Lukas, J. (2006) Claspin operates downstream of TopBP1 to direct ATR signaling towards Chk1 activation. Mol. Cell Biol., 26, 6056-6064.
51. Zhang, Y.W., Otterness, D.M., Chiang, G.G., Xie, W., Liu, Y.C., Mercurio, F. and Abraham, R.T. (2005) Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol. Cell, 19, 607-618.
52. Jacquemont, C. and Taniguchi, T. (2007) Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res., 67, 7395-7405.
53. Hu, J., McCall, C.M., Ohta, T. and Xiong, Y. (2004) Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage. Nat. Cell Biol., 6, 1003-1009.
54. Lee, J. and Zhou, P. (2007) DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol. Cell, 26, 775-780.
55. Howlett, N.G., Harney, J.A., Rego, M.A., Kolling, F.W.T. and Glover, T.W. (2009) Functional interaction between the Fanconi Anemia D2 protein and proliferating cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif. J. Biol. Chem., 284, 28935-28942.
56. Song, I.Y., Palle, K., Gurkar, A., Tateishi, S., Kupfer, G.M. and Vaziri, C. (2010) Rad18-mediated translesion synthesis of bulky DNA adducts is coupled to activation of the Fanconi anemia DNA repair pathway. J. Biol. Chem., 285, 31525-31536.
57. Akkari, Y.M., Bateman, R.L., Reifsteck, C.A., D'Andrea, A.D., Olson, S.B. and Grompe, M. (2001) The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol. Genet. Metab., 74, 403-412.
58. Ben-Yehoyada, M., Wang, L.C., Kozekov, I.D., Rizzo, C.J., Gottesman, M.E. and Gautier, J. (2009) Checkpoint signaling from a single DNA interstrand crosslink. Mol. Cell, 35, 704-715.
59. Singh, T.R., Bakker, S.T., Agarwal, S., Jansen, M., Grassman, E., Godthelp, B.C., Ali, A.M., Du, C.H., Rooimans, M.A., Fan, Q. et al. (2009) Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M. Blood, 114, 174-180.
60. Collis, S.J., Ciccia, A., Deans, A.J., Horejsi, Z., Martin, J.S., Maslen, S.L., Skehel, J.M., Elledge, S.J., West, S.C. and Boulton, S.J. (2008) FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol. Cell, 32, 313-324.
61. Ceccaldi, R., Briot, D., Larghero, J., Vasquez, N., Dubois d'Enghien, C., Chamousset, D., Noguera, M.E., Waisfisz, Q., Hermine, O., Pondarre, C. et al. (2011) Spontaneous abrogation of the G DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients. J. Clin. Invest., 121, 184-194.